UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
ASSETS
Cash and cash equivalents	$ 7,081	$ 13,490
Restricted cash and equivalents	148,063	149,299
Finance receivables measured at fair value	2,618,420	2,476,617
Finance receivables	52,080	92,304
Less: Allowance for finance credit losses	(5,721)	(21,753)
Finance receivables, net	46,359	70,551
Furniture and equipment, net	1,284	1,660
Deferred tax assets, net	7,367	10,177
Other assets	25,304	30,974
Total Assets	2,853,878	2,752,768
Liabilities
Accounts payable and accrued expenses	57,384	55,421
Warehouse lines of credit	245,272	285,328
Residual interest financing	49,749	49,623
Securitization trust debt	2,225,072	2,108,744
Subordinated renewable notes	21,204	25,263
Total liabilities	2,598,681	2,524,379
COMMITMENTS AND CONTINGENCIES
Shareholders' Equity
Common stock, no par value; authorized 75,000,000 shares; 21,151,966 and 20,131,323 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	27,937	28,906
Retained earnings	230,291	202,514
Accumulated other comprehensive loss	(3,031)	(3,031)
Total stockholders’ equity	255,197	228,389
Total liability and stockholder’ equity	2,853,878	2,752,768
Preferred Stock [Member]
Shareholders' Equity
Preferred Stock, Value, Issued	0	0
Series A Preferred Stock [Member]
Shareholders' Equity
Preferred Stock, Value, Issued	0	0
Series B Preferred Stock [Member]
Shareholders' Equity
Preferred Stock, Value, Issued	$ 0	$ 0